CN212308676U - Full-coverage low-energy photon type bromhidrosis eliminator - Google Patents
Full-coverage low-energy photon type bromhidrosis eliminator Download PDFInfo
- Publication number
- CN212308676U CN212308676U CN201922426131.7U CN201922426131U CN212308676U CN 212308676 U CN212308676 U CN 212308676U CN 201922426131 U CN201922426131 U CN 201922426131U CN 212308676 U CN212308676 U CN 212308676U
- Authority
- CN
- China
- Prior art keywords
- eliminator
- energy photon
- source
- photon type
- full
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000035985 Body Odor Diseases 0.000 title claims abstract description 20
- 206010055000 Bromhidrosis Diseases 0.000 title claims abstract description 20
- 238000011282 treatment Methods 0.000 claims abstract description 14
- 239000000463 material Substances 0.000 claims description 5
- 239000000853 adhesive Substances 0.000 claims description 3
- 230000001070 adhesive effect Effects 0.000 claims description 3
- 229920001971 elastomer Polymers 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 229910000990 Ni alloy Inorganic materials 0.000 claims description 2
- 229920002379 silicone rubber Polymers 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 4
- 230000001225 therapeutic effect Effects 0.000 abstract description 3
- 208000008454 Hyperhidrosis Diseases 0.000 abstract 1
- 230000037315 hyperhidrosis Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 description 9
- 210000000040 apocrine gland Anatomy 0.000 description 5
- 238000001959 radiotherapy Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 3
- 208000002557 hidradenitis Diseases 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 231100000987 absorbed dose Toxicity 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000002324 minimally invasive surgery Methods 0.000 description 2
- 238000000554 physical therapy Methods 0.000 description 2
- 239000011505 plaster Substances 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 241000304886 Bacilli Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 230000005461 Bremsstrahlung Effects 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- NOQGZXFMHARMLW-UHFFFAOYSA-N Daminozide Chemical compound CN(C)NC(=O)CCC(O)=O NOQGZXFMHARMLW-UHFFFAOYSA-N 0.000 description 1
- 101000583175 Homo sapiens Prolactin-inducible protein Proteins 0.000 description 1
- 206010036410 Postoperative wound infection Diseases 0.000 description 1
- 102100030350 Prolactin-inducible protein Human genes 0.000 description 1
- 206010040893 Skin necrosis Diseases 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 206010042345 Subcutaneous haematoma Diseases 0.000 description 1
- 208000031650 Surgical Wound Infection Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000002725 brachytherapy Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000005251 gamma ray Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 238000011369 optimal treatment Methods 0.000 description 1
- 238000002638 palliative care Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000001050 pharmacotherapy Methods 0.000 description 1
- 238000004663 powder metallurgy Methods 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Images
Landscapes
- Radiation-Therapy Devices (AREA)
Abstract
The invention relates to a short-distance therapeutic device for eliminating underarm odour, which is called a full-coverage low-energy photon type underarm odour eliminating applicator or a full-coverage low-energy photon type underarm odour eliminator for short. It is composed of seed source, source holder, protecting sleeve, bottom liner and connecting device. The underarm hyperhidrosis can be completely covered and applied to the armpit of a patient by using low-energy photons emitted by a plurality of I-125 seed sources arranged in the source support, so that the aim of eliminating the underarm odor is fulfilled. The full-coverage low-energy photon type bromhidrosis eliminator provides a novel treatment means with good curative effect, no wound, no pain and more flexibility for bromhidrosis patients.
Description
A technical field
The utility model relates to a medical appliance, in particular to a medical appliance which adopts low-energy photons to implement short-distance treatment, which is called as a full-coverage low-energy photon type axillary odor eliminating applicator or a full-coverage low-energy photon type axillary odor eliminator for short.
A full-coverage low-energy photon type bromhidrosis eliminator is specially used for treating bromhidrosis patients.
Second, background Art
Bromhidrosis, also known as bromhidrosis, is characterized in that sweat containing protein components is secreted from axillary apocrine glands of a patient, and is decomposed by bacteria (containing staphylococcus epidermidis and gram-negative bacilli) at the moist parts of axillary pit to emit typical unpleasant rotten onion-garlic odor after being discharged out of the body. The disease is more in the middle-aged and has certain heredity and ethnicity.
The treatment method comprises the following steps: pharmacotherapy, physiotherapy, operation therapy and application radiotherapy.
1. The drug therapy comprises the following steps: including medicine applying method or medicine injecting method, and belongs to the field of palliative treatment.
2. Physical therapy: is divided into laser, high frequency, freezing, etc. The method can improve the bromhidrosis in different degrees, but mostly treats the symptoms and the root causes.
3. Surgery treatment: it is suitable for moderate and severe patients. The traditional surgical method is to cut the skin of the axillary hair together with the apocrine gland. This method has a feeling of traction after surgery and scars.
In recent years "minimally invasive surgery" has emerged. The method has slight wound and small scar. But the patients are required to be physically healthy before operation and to have a complete physical examination and to stop some medicines. In addition, the minimally invasive surgery has certain risks like the traditional surgical operation, such as postoperative wound infection, subcutaneous hematoma, skin necrosis and the like, and also has the problem of a small recurrence rate.
4. Applying for radiotherapy. Including the domestic "Sr-90 skin applicator" developed in the nineties of the last century and the "beta-particle bromhidrosis therapeutic instrument" developed in recent years (see the Chinese patent ZL 200820180846.8). They all utilize beta particles emitted by Sr-90/Y-90 sealed radioactive source and small amount of bremsstrahlung radiation to act on apocrine sweat gland which can dry and secrete stink, so as to produce ionization action, and the cell of apocrine sweat gland is inactivated, thus achieving the purpose of eliminating stink.
The dry Sr-90/Y-90 (beta) sealed radioactive source is required to be made into a foil source (manufactured by powder metallurgy technology), but the current supply in China is not recovered, and a new way is needed.
The flexible low-energy photon skin applicator developed in 2014 (XL201420852731.4) can be used as the skin applicator90Sr/90Complement and alternative to the Y skin applicator (rigid).
Can be used for treating common dermatoses by applying radiotherapy, and can be combined with flexible low-energy photon skin applicator in clinic90Sr/90The Y skin applicator (stiffness) was comparable. However, for bromhidrosis elimination, due to the special treatment site, flexible low-energy photon skin applicator is not used, and rigid skin applicator is used90Sr/90Y skin applicator (applicator active region size is 20mm), all need move many times just can cover armpit area of apocrine sweat when shining the treatment each time, in order not to influence the curative effect, should avoid appearing phenomenon such as "overlapping" or "blind area" when shining as far as possible, whole operation process is very troublesome, operating time is also long.
The utility model aims at overcoming above-mentioned shortcoming, develop the elimination armpit odor application apparatus of the more nimble full-coverage formula of having no wound, be called for short "full-coverage low energy light type armpit odor annihilator", can directly implement the surface application treatment to the armpit apocrine gland of armpit odor patient, also can carry out the adjunctie therapy to remaining gland after the operation treatment.
Third, the invention
The utility model discloses, full coverage low energy photon type armpit odor eliminator comprises seed source, source support, sheath, end liner and connecting device (see structure picture 1). Wherein the seed source is I-125 sealed seed source, and the energy of gamma ray (35.5 keV) and characteristic X ray (27.4-31.4 KeV) is low, so that the method is very suitable for brachytherapy. The higher irradiation dose can be obtained for the lesion tissue, and the lower irradiation dose can be obtained for the adjacent surrounding tissues, so that the radiation damage can be greatly reduced. Therefore, the radiation safety of medical staff and patients during treatment can be ensured for clinical use.
The utility model discloses, the used source support of full coverage low energy photon type armpit odor eliminator is held in the palm by the left and right source of symmetry and is constituteed, and medical silicon rubber is chooseed for use to the material, can inlay 15-20 seed sources respectively.
The utility model discloses, the underenergy photon type armpit odor eliminator of full coverage, source hold in the palm has the sheath protection all around. The sheath is composed of a left sheath and a right sheath which are symmetrical, the material is lead rubber, the lead equivalent is 0.25mm Pb-0.35 mm Pb, and the lead rubber is used for shielding low-energy photons scattered from the periphery by a source support embedded with a seed source.
The utility model discloses, the source of full coverage low energy photon type armpit odor eliminator holds in the palm the snap-on the end liner, and it comprises the left and right end liner of symmetry. Ta or W-Ni alloy sheets (the thickness is 0.4-0.5mm) are selected as materials and used for shielding low-energy photons emitted by the back of a source support embedded with a seed source.
The utility model discloses, the complete underarm odour eliminator is assembled into to left and right end liner (can be regarded as left and right both wings) to full coverage low energy photon type underarm odour eliminator adopts connecting device, can implement the expansion (180) of both wings or draw in (0) action in to let the patient arm extend the activity freely during treatment.
The utility model discloses, full coverage low energy photon type armpit odor eliminator adopts medical bonding dressing will inlay the left and right end liner that has the seed source and be fixed in patient armpit central both sides, can implement the application of ointment or plaster treatment of armpit odor eliminator full coverage armpit sweat gland.
The underarm odor eliminator can fully cover the underarm apocrine gland area by the low-energy photon rays emitted by the I-125 sealed seed source, and each irradiation is completed once without being performed for multiple times, so that the defects of overlapping or blind areas and the like possibly occurring during irradiation are overcome, the operation is more flexible, and patients have no uncomfortable feeling.
Description of the drawings
Fig. 1 is a view showing the structure of a full-covered low-energy photon type axillary odor eliminator, wherein 1 is a seed source, 2 is a source holder, 3 is a sheath, 4 is a bottom liner, and 5 is a connecting device.
Detailed description of the preferred embodiments
The following are examples.
The utility model discloses, full coverage low energy photon type armpit odor annihilator is held in the palm 2 by seed source 1, source, sheath 3, end liner 4 and connecting device 5 and is constituteed (see structure diagram 1).
The novel therapeutic apparatus for eliminating the bromhidrosis adopts an I-125 sealed seed source which emits low-energy photons, and can implement application radiotherapy which completely covers the axillary apocrine gland area. The integral underarm odour eliminator is assembled by a connecting device, namely a hinge, and left and right wing underarm odour eliminators which are embedded with seed sources and are symmetrical to each other are adopted. The overall bromhidrosis eliminator is in an ellipsoid shape, the minor axis is 45-50mm, and the major axis is 90-110mm.
The left and right alar osmidrosis eliminators are respectively inlaid with 15-20 seed sources. The total amount of the axillary odor eliminator uses 30-40I-125 seed sources. The initial radioactivity requirement of the single seed source reaches 0.7mCi to 1.0 mCi. The total radioactivity ranged from 20-40 mCi.
In clinical application, the local skin of the armpit is firstly cleaned and disinfected conventionally. Then the whole body axillary odor eliminator is applied to the diseased region, and the left and right two-wing axillary odor eliminator are fixed respectively by medical adhesive dressing such as adhesive plaster with good air permeability (note: the front of the active region of each wing, i.e. the low-energy photon emission window, must be aligned to the two sides of the center of the axillary pit of the patient).
Because the whole bromhidrosis eliminator is connected by hinges, the bromhidrosis eliminator can be unfolded (maximally 180 degrees) and also folded (minimally 0 degrees), so that the patient can not be restricted in arm movement and can freely extend to the patient during the application treatment.
Once the whole bromhidrosis suppressor is fixed, the application radiotherapy of the axillary apocrine sweat gland is started, and the irradiation time is calculated according to the set absorption dose. The total absorbed dose is controlled at 15-20 Gy. The first irradiation can adopt a larger absorbed dose, and then 2-3 times of small-dose irradiation is given, so that the patient can be properly adjusted in time according to individual differences of the patient to obtain the optimal treatment effect. After each treatment, the integral bromhidrosis eliminator is taken down and stored in a shielding tank for later use after disinfection.
Claims (7)
1. A full-coverage low-energy photon type bromhidrosis eliminator is characterized by comprising a seed source, a source support, a sheath, a bottom liner and a connecting device, wherein the seed source is a multi-particle I-125 sealed seed source, and low-energy photons emitted by the seed source are used for carrying out irradiation treatment on the armpit of a bromhidrosis patient.
2. The full coverage low energy photon type bromhidrosis eliminator as claimed in claim 1, wherein the source holder is composed of symmetrical left and right source holders, the material is selected from medical silicon rubber, 15-20 seed sources can be inlaid respectively.
3. The full coverage low energy photon type axillary odor eliminator as claimed in claim 1, wherein the sheath is composed of a left sheath and a right sheath which are symmetrical, the material is lead rubber, the lead equivalent is 0.25mm Pb-0.35 mm Pb.
4. The full coverage low energy photon type axillary odor eliminator as claimed in claim 1, wherein the bottom liner is composed of left and right symmetric bottom liners made of Ta or W-Ni alloy sheet.
5. The full coverage low energy photon type axillary odor eliminator as claimed in claim 1, wherein the source holder embedded with the seed source is fixed in the bottom lining with the sheath around.
6. The full coverage low energy photon type tragomaschalia eliminator as claimed in claim 1 or 5, wherein the left and right bottom linings are assembled into an integral tragomaschalia eliminator by using a connecting device.
7. The full coverage low energy photon type axillary odor eliminator of claim 1, wherein the integrated axillary odor eliminator embedded with a seed source is fixed at the axillary of the patient by using medical adhesive dressing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201922426131.7U CN212308676U (en) | 2019-12-30 | 2019-12-30 | Full-coverage low-energy photon type bromhidrosis eliminator |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201922426131.7U CN212308676U (en) | 2019-12-30 | 2019-12-30 | Full-coverage low-energy photon type bromhidrosis eliminator |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN212308676U true CN212308676U (en) | 2021-01-08 |
Family
ID=74029725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201922426131.7U Active CN212308676U (en) | 2019-12-30 | 2019-12-30 | Full-coverage low-energy photon type bromhidrosis eliminator |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN212308676U (en) |
-
2019
- 2019-12-30 CN CN201922426131.7U patent/CN212308676U/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Skowronek | Current status of brachytherapy in cancer treatment–short overview | |
| US20090312593A1 (en) | Radioactive Device for treatment of a Tumor | |
| Stannard et al. | Iodine-125 brachytherapy in the management of squamous cell carcinoma of the oral cavity and oropharynx | |
| Kraus-Tiefenbacher et al. | A novel mobile device for intraoperative radiotherapy (IORT) | |
| Powers et al. | Preoperative irradiation in head and neck cancer surgery | |
| Moylan et al. | Work in progress. Transbronchial brachytherapy of recurrent bronchogenic carcinoma: a new approach using the flexible fiberoptic bronchoscope. | |
| US10350433B2 (en) | Layer structure for epidermal radionuclide therapy | |
| Samuel et al. | A pilot study of radical radiotherapy using a perioperative implant following wide local excision for carcinoma of the breast | |
| CN212308676U (en) | Full-coverage low-energy photon type bromhidrosis eliminator | |
| Hayter et al. | Necrosis following radiotherapy for carcinoma of the pinna | |
| US8444544B1 (en) | Device and method for intensity modulated brachytherapy | |
| Holt et al. | Miniature x-ray tubes will ultimately displace Ir-192 as the radiation sources of choice for high dose rate brachytherapy. | |
| Aronowitz | Buried emanation: the development of seeds for permanent implantation | |
| Rubenfeld et al. | Treatment of bronchogenic cancer with conventional x-rays according to a specific time-dose pattern | |
| Wong et al. | Radiation therapy in the management of cutaneous malignancies | |
| Vtyurin et al. | Neutron brachytherapy in the treatment of melanoma | |
| Levitt et al. | Complications and late changes following radiation therapy for carcinoma of the eyelid and canthi | |
| Luca et al. | Interventional Radiotherapy (Brachytherapy) for the Treatment of Primary Lesions in Nasal Vestibule Malignancies | |
| Burnet | Radiotherapy as a treatment for breast cancer | |
| Dar et al. | Secondary cutaneous involvement in follicular diffuse lymphoma treated with helical tomotherapy | |
| Свинаренко et al. | Brachytherapy in comprehensive treatment of breast cancer | |
| Burnet | 9 Radiotherapy as a Treatment | |
| Vaidya et al. | Targeted intraoperative radiotherapy for breast cancer: Not all cancers in the breast will grow | |
| Gadbois et al. | High dose rate skin brachytherapy: a compassionate, cost-effective alternative | |
| Mohamed et al. | Medical Physicists’ Roles and Responsibilities |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant |